AlphaYouBN
Insider selling
Bruce N. Jacobs sold $8.9M of Kymera Therapeutics, Inc. (KYMR) stock
Bruce N. Jacobs, Chief Financial Officer of Kymera Therapeutics, Inc. (KYMR), sold 77,109 shares of KYMR stock worth $8.9M, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 30, 2026, 2 days before it was made public.
KYMR has moved -3.6% since the trade date, from $114.67 to $110.51 (Sep 29, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 2 days
- Price since
- -3.6%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More KYMR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.